Harrison H N, Shuck J M, Caldwell E
Arch Surg. 1975 Dec;110(12):1446. doi: 10.1001/archsurg.1975.01360180016003.
In a double-blind triple cross-over clinical study, 37 patients were exposed to several formulations of mafenide acetate (Sulfamylon Cream) and their pain responses were recorded and converted to a semiquantitative pain index. The 11.2% concentration in cream was two to three times more painful than the 5% concentration. Hypertonicity and not the pH level appears to be the cause of the pain produced by the high (11.2%) concentration. The tonicity of the cream carrier and 11.2% mafenide acetate are 1,080 mOsm/kg and 1,100 mOsm/kg, respectively, for a total of 2,180 mOsm/kg. The carrier cream without glycerol and a 5% concentration of mafenide cream were much less painful than the 11.2% concentration of mafenide. Both afforded a great deal of relief to the patients who received the medications.
在一项双盲三交叉临床研究中,37名患者接触了几种醋酸磺胺米隆(磺胺米隆乳膏)制剂,并记录了他们的疼痛反应,将其转换为半定量疼痛指数。乳膏中11.2%的浓度比5%的浓度疼痛程度高出两到三倍。高渗性而非pH值似乎是高浓度(11.2%)产生疼痛的原因。乳膏载体和11.2%醋酸磺胺米隆的渗透压分别为1080 mOsm/kg和1100 mOsm/kg,总计2180 mOsm/kg。不含甘油的载体乳膏和5%浓度的磺胺米隆乳膏比11.2%浓度的磺胺米隆疼痛程度要低得多。两者都为接受药物治疗的患者带来了很大程度的缓解。